Soleno Therapeutics Cash from Financing (TTM) Insights

Soleno Therapeutics Inc (SLNO)

45.02 -2.62 (-5.49%) USD | NASDAQ | May 10, 16:00

45.02 0.00 (0.00%) After-Hours: 18:39

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	180.02M
September 30, 2023	56.46M
June 30, 2023	17.40M
March 31, 2023	0.06M
December 31, 2022	14.09M
September 30, 2022	14.09M
June 30, 2022	13.74M
March 31, 2022	14.03M
December 31, 2021	-0.128M
September 30, 2021	-0.165M
June 30, 2021	-0.36M
March 31, 2021	53.60M
December 31, 2020	53.72M
September 30, 2020	68.24M
June 30, 2020	68.44M
March 31, 2020	14.48M
December 31, 2019	14.48M
September 30, 2019	16.30M
June 30, 2019	17.00M
March 31, 2019	17.54M
December 31, 2018	17.83M

Date	Value
September 30, 2018	15.70M
June 30, 2018	15.00M
March 31, 2018	14.46M
December 31, 2017	24.17M
September 30, 2017	10.00M
June 30, 2017	15.70M
March 31, 2017	15.77M
December 31, 2016	10.77M
September 30, 2016	14.95M
June 30, 2016	10.56M
March 31, 2016	10.78M
December 31, 2015	9.158M
September 30, 2015	14.45M
June 30, 2015	13.26M
March 31, 2015	14.58M
December 31, 2014	11.20M
September 30, 2014	1.723M
June 30, 2014	1.604M
March 31, 2014	0.00
December 31, 2013	0.00

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.36M

Minimum

Jun 2021

180.02M

Maximum

Dec 2023

32.40M

Average

14.48M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks